1. Home
  2. INVE vs BYSI Comparison

INVE vs BYSI Comparison

Compare INVE & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Identiv Inc.

INVE

Identiv Inc.

HOLD

Current Price

$2.81

Market Cap

63.6M

Sector

Technology

ML Signal

HOLD

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

N/A

Current Price

$1.27

Market Cap

58.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INVE
BYSI
Founded
1990
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.6M
58.4M
IPO Year
1997
2016

Fundamental Metrics

Financial Performance
Metric
INVE
BYSI
Price
$2.81
$1.27
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$5.50
N/A
AVG Volume (30 Days)
360.8K
25.7K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$60,219,000.00
N/A
Revenue This Year
$22.10
N/A
Revenue Next Year
$20.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.21
N/A
52 Week Low
$2.43
$1.16
52 Week High
$5.30
$2.44

Technical Indicators

Market Signals
Indicator
INVE
BYSI
Relative Strength Index (RSI) 37.20 30.50
Support Level $2.43 $1.18
Resistance Level $3.83 $1.85
Average True Range (ATR) 0.16 0.14
MACD 0.05 -0.05
Stochastic Oscillator 51.72 14.47

Price Performance

Historical Comparison
INVE
BYSI

About INVE Identiv Inc.

Identiv Inc develops specialty radio-frequency identification (RFID) and Internet of Things It (IoT) solutions that address customers' challenges and create new opportunities for them through the digitization and enhanced connectivity to the IoT. It designs, produces, and sells RFID and Bluetooth Low Energy (BLE) enabled devices, RFID inlays, tags, and labels that can be applied or incorporated into physical objects, providing them with a digital identity and the ability for customers to track, monitor, authenticate, and engage with consumers. Its IoT Business segment develops, manufactures, and supplies specialty IoT solutions tailored for the healthcare, logistics, smart packaging industries and other high-value end markets.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

Share on Social Networks: